These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1389 related items for PubMed ID: 22865868

  • 1. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J, Potocki M, Murray K, Breidthardt T, Ziller R, Mosimann T, Klima T, Hoeller R, Moehring B, Sou SM, Rubini Gimenez M, Morgenthaler NG, Mueller C.
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [Abstract] [Full Text] [Related]

  • 2. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 3. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A, Lloyd-Jones DM, Chae CU, van Kimmenade RR, Chen AC, Baggish AL, O'Donoghue M, Lee-Lewandrowski E, Januzzi JL.
    Am Heart J; 2007 Jan 13; 153(1):90-7. PubMed ID: 17174644
    [Abstract] [Full Text] [Related]

  • 4. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD.
    J Am Coll Cardiol; 2010 May 11; 55(19):2062-76. PubMed ID: 20447528
    [Abstract] [Full Text] [Related]

  • 5. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
    Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG.
    Eur Heart J; 2006 Oct 11; 27(19):2353-61. PubMed ID: 16952921
    [Abstract] [Full Text] [Related]

  • 6. Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.
    Porcel JM, Bielsa S, Morales-Rull JL, Civit C, Cao G, Light RW, Esquerda A.
    Respirology; 2013 Apr 11; 18(3):540-5. PubMed ID: 23278975
    [Abstract] [Full Text] [Related]

  • 7. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).
    Richards M, Di Somma S, Mueller C, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Clopton P, Filippatos GS, Anand I, Ng L, Daniels LB, Neath SX, Shah K, Christenson R, Hartmann O, Anker SD, Maisel A.
    JACC Heart Fail; 2013 Jun 11; 1(3):192-9. PubMed ID: 24621869
    [Abstract] [Full Text] [Related]

  • 8. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
    Dixen U, Ravn L, Soeby-Rasmussen C, Paulsen AW, Parner J, Frandsen E, Jensen GB.
    Cardiology; 2007 Jun 11; 108(1):35-9. PubMed ID: 16968988
    [Abstract] [Full Text] [Related]

  • 9. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
    Seronde MF, Gayat E, Logeart D, Lassus J, Laribi S, Boukef R, Sibellas F, Launay JM, Manivet P, Sadoune M, Nouira S, Solal AC, Mebazaa A, Great network.
    Int J Cardiol; 2013 Oct 09; 168(4):3404-11. PubMed ID: 23684562
    [Abstract] [Full Text] [Related]

  • 11. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure.
    Corell P, Gustafsson F, Kistorp C, Madsen LH, Schou M, Hildebrandt P.
    Int J Cardiol; 2007 May 02; 117(3):395-402. PubMed ID: 16919342
    [Abstract] [Full Text] [Related]

  • 12. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ.
    Europace; 2006 Jul 02; 8(7):482-7. PubMed ID: 16798760
    [Abstract] [Full Text] [Related]

  • 13. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.
    Shah RV, Truong QA, Gaggin HK, Pfannkuche J, Hartmann O, Januzzi JL.
    Eur Heart J; 2012 Sep 02; 33(17):2197-205. PubMed ID: 22645194
    [Abstract] [Full Text] [Related]

  • 14. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P, Bahrmann A, Hofner B, Christ M, Achenbach S, Sieber CC, Bertsch T.
    Eur Heart J Acute Cardiovasc Care; 2015 Apr 02; 4(2):137-47. PubMed ID: 25002708
    [Abstract] [Full Text] [Related]

  • 15. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO, Winther JA, Brynildsen J, Strand H, Christensen G, Høiseth AD, Myhre PL, Røysland R, Lyngbakken MN, Omland T, Røsjø H.
    Biomarkers; 2018 Nov 02; 23(7):654-663. PubMed ID: 29733687
    [Abstract] [Full Text] [Related]

  • 16. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A, Struck J, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T.
    Clin Chem; 2006 May 02; 52(5):827-31. PubMed ID: 16543387
    [Abstract] [Full Text] [Related]

  • 17. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure.
    Potocki M, Breidthardt T, Reichlin T, Hartwiger S, Morgenthaler NG, Bergmann A, Noveanu M, Freidank H, Taegtmeyer AB, Wetzel K, Boldanova T, Stelzig C, Bingisser R, Christ M, Mueller C.
    J Intern Med; 2010 Jan 02; 267(1):119-29. PubMed ID: 19570053
    [Abstract] [Full Text] [Related]

  • 18. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V, Jurkovicová O, Kaluzay J, Stecová A, Pont'uch P.
    Vnitr Lek; 2010 Aug 02; 56(8):788-94. PubMed ID: 20845610
    [Abstract] [Full Text] [Related]

  • 19. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH, Camargo CA, Krauser D, Anwaruddin S, Baggish A, Chen A, Januzzi JL.
    Ann Emerg Med; 2006 Jul 02; 48(1):66-74. PubMed ID: 16781921
    [Abstract] [Full Text] [Related]

  • 20. Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation.
    Nilsson B, Goetze JP, Chen X, Pehrson S, Svendsen JH.
    Scand J Clin Lab Invest; 2009 Jul 02; 69(8):843-50. PubMed ID: 19929271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.